Know Cancer

or
forgot password

Study Evaluating the Interest of Cytology-molecular Tumor Markers Association for the Diagnostic Strategy in Adult Kidney Tumors


N/A
18 Years
N/A
Open (Enrolling)
Both
Kidney Neoplasms

Thank you

Trial Information

Study Evaluating the Interest of Cytology-molecular Tumor Markers Association for the Diagnostic Strategy in Adult Kidney Tumors


Inclusion Criteria:



- Clinical diagnosis of kidney tumor < 4 cm

- Cystic kidney tumor (Bosniak > IIF)

- Consent signed

Exclusion Criteria:

- Benign tumor confirmed

- Impossibility to do abdominal pelvic ultra-sound or abdominal thoracic scanner

- Contraindication for renal puncture

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Histologic diagnostic (tumor)

Outcome Time Frame:

after surgery or biopsy

Safety Issue:

No

Principal Investigator

Jacques TOSTAIN, PhD-MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

CHU de Saint-Etienne

Authority:

France: French Data Protection Authority

Study ID:

0501106

NCT ID:

NCT00491621

Start Date:

April 2007

Completion Date:

January 2015

Related Keywords:

  • Kidney Neoplasms
  • kidney
  • tumor
  • Molecular Markers
  • Cytology
  • Histology
  • Cystic kidney tumor
  • Neoplasms
  • Kidney Neoplasms

Name

Location